Biodexa Pharmaceuticals Plc
BDRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001643918
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Biodexa Pharmaceuticals Plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 8 | 5 | −3 |
| Shares | 670.5K | 12.1K | −658.4K (−98.2%) |
| Value | $45.8K | $58.9K | +$13.1K (+28.6%) |
New holders (2)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 11,737 | $57.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 51 | $254 | 0.00% |
Sold out (5)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 265,993 | $18.2K |
| Millennium Management LLC | 204,300 | $14.0K |
| Two Sigma Securities, LLC | 37,865 | $2.60K |
| Baader Bank INC | 16,250 | $865 |
| Federation des caisses Desjardins du Quebec | 180 | $12 |